Endocrinology & Diabetes

Diabetic Complications: Kidney, Cardiovascular & Retinal

Diabetic complications remain a leading cause of morbidity, and this track offers a deep exploration of their underlying mechanisms and clinical implications. Experts will discuss microvascular and macrovascular injury pathways, oxidative stress, endothelial dysfunction, and advanced glycation end-product–mediated damage. A particular focus will be placed on diabetic nephropathy, including early biomarkers of kidney damage, the progression toward chronic kidney disease, and new therapeutic strategies that slow or reverse decline. Similarly, retinal complications—including retinopathy, macular edema, and neurodegeneration—will be covered with emphasis on emerging imaging tools and diagnostic technologies.

The cardiovascular segment addresses the intricate connections between diabetes, atherosclerosis, thrombosis, and heart failure. Presentations will highlight how novel medications such as SGLT2 inhibitors and GLP-1 RAs reshape risk profiles and improve organ outcomes beyond glycemic control. Attendees will also explore multidisciplinary management models, population-wide screening strategies, and personalized monitoring programs designed to detect complications earlier and improve long-term prognosis. This track provides a comprehensive view of how pathophysiology, technology, and advanced therapy converge to protect vital organs in diabetes care.